BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/19/2026 2:35:55 AM | Browse: 3 | Download: 2
Publication Name World Journal of Immunology
Manuscript ID 125225
Country United States
Received
2026-07-02 02:52
Peer-Review Started
2026-07-02 02:53
First Decision by Editorial Office Director
Return for Revision
2026-07-20 07:40
Revised
2026-08-02 03:58
Publication Fee Transferred
Editorial Processing by Scientific Editor
2026-10-16 03:39
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2026-10-16 09:26
Articles in Press
2026-10-16 09:26
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-10-23 09:30
Publish the Manuscript Online
2026-11-19 02:35
ISSN 2219-2824 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Metabolic inflammation in metabolic dysfunction-associated steatotic liver disease
Manuscript Source Invited Manuscript
All Author List Chun-Ye Zhang and Ming Yang
ORCID
Author(s) ORCID Number
Chun-Ye Zhang http://orcid.org/0000-0003-2567-029X
Ming Yang http://orcid.org/0000-0002-4895-5864
Funding Agency and Grant Number
Corresponding Author Ming Yang, Assistant Professor, PhD, Department of Surgery, School of Medicine, University of Connecticut, 263 Farmington Avenue, Farmington, CT 06030, United States. minyang@uchc.edu
Key Words Metainflammation; Metabolic dysfunction-associated steatotic liver disease; Metabolic dysfunction and alcohol-associated liver disease; Lipid metabolism; Immunity; Liver fibrosis; Clinical trials
Core Tip Metainflammation contributes to the pathogenesis of numerous metabolic disorders and chronic diseases, including metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction and alcohol-associated liver disease (MetALD). It promotes hepatic lipid accumulation, inflammation, fibrosis, and cell death, thereby accelerating the progression of MASLD or MetALD to cirrhosis and liver cancer. Therapeutic strategies targeting metainflammation, including gut microbiome-directed therapies, dietary modulation, antioxidant interventions, and modulation of lipid metabolism, represent promising therapies for metabolic liver diseases.
Publish Date 2026-11-19 02:35
Citation

Zhang CY, Yang M. Metabolic inflammation in metabolic dysfunction-associated steatotic liver disease. World J Immunol 2026; 16(3): 125225

URL https://www.wjgnet.com/2219-2824/full/v16/i3/125225.htm
DOI https://doi.org/10.5411/wji.125225
Full Article (PDF) WJI-16-125225-with-cover.pdf